中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2010年
12期
925-927
,共3页
周彦明%杨甲梅%陈福真%李秀东%许东辉%苏旭%李滨
週彥明%楊甲梅%陳福真%李秀東%許東輝%囌旭%李濱
주언명%양갑매%진복진%리수동%허동휘%소욱%리빈
癌,肝细胞%妊娠%甲胎蛋白
癌,肝細胞%妊娠%甲胎蛋白
암,간세포%임신%갑태단백
Carcinoma hepatocellular%Pregnancy%α-fetoprotein
目的 探讨妊娠期肝细胞癌(hepatocellular carcinoma,HCC)的临床特征.方法 回顾性分析4例妊娠期HCC病人的临床资料.结果 4例病人乙肝表面抗原均为阳性,3例血清甲胎蛋白水平明显增高(310.1~5630.0 ng/m1).3例病人在诊断时HCC已为晚期,分别于诊断后第7个月、第6个月、第4个月病死.1例早期HCC行根治性切除后已无瘤生存26个月.结论 妊娠期HCC就诊时多为疾病晚期预后差.建议对妊娠期妇女特别是乙肝流行区域的乙肝携带者行甲胎蛋白和肝脏超声筛查,以早期发现HCC,提高生存期.
目的 探討妊娠期肝細胞癌(hepatocellular carcinoma,HCC)的臨床特徵.方法 迴顧性分析4例妊娠期HCC病人的臨床資料.結果 4例病人乙肝錶麵抗原均為暘性,3例血清甲胎蛋白水平明顯增高(310.1~5630.0 ng/m1).3例病人在診斷時HCC已為晚期,分彆于診斷後第7箇月、第6箇月、第4箇月病死.1例早期HCC行根治性切除後已無瘤生存26箇月.結論 妊娠期HCC就診時多為疾病晚期預後差.建議對妊娠期婦女特彆是乙肝流行區域的乙肝攜帶者行甲胎蛋白和肝髒超聲篩查,以早期髮現HCC,提高生存期.
목적 탐토임신기간세포암(hepatocellular carcinoma,HCC)적림상특정.방법 회고성분석4례임신기HCC병인적림상자료.결과 4례병인을간표면항원균위양성,3례혈청갑태단백수평명현증고(310.1~5630.0 ng/m1).3례병인재진단시HCC이위만기,분별우진단후제7개월、제6개월、제4개월병사.1례조기HCC행근치성절제후이무류생존26개월.결론 임신기HCC취진시다위질병만기예후차.건의대임신기부녀특별시을간류행구역적을간휴대자행갑태단백화간장초성사사,이조기발현HCC,제고생존기.
Objective To explore the clinical features of hepatocellular carcinoma (HCC) during pregnancy. Methods Clinical data of 4 patients with HCC in pregnancy were retrospectively analyzed.Results All 4 patients were positive for hepatitis B surface antigen. A marked increase in maternal serum a-fetoprotein (AFP) was found in 3 patients (310.1-5630.0 ng/ml ). Three patients were diagnosed at their advanced stages and died of disease in the 4th, 6th and 7th months, respectively. One patient diagnosed as having early HCC underwent curative surgery and has been without recurrence for 26 months. Conclusion The overall survival of patients with HCC in pregnancy is grim because most patients are diagnosed in the advanced stage. Surveillance with AFP and ultrasonography should be recommended for pregnant woman for the detection of early HCC, especially in hepatitis B virus carriers from high endemic areas, to improve patient survival.